Amphetamine Completed Phase 4 Trials for Attention Deficit Disorder With Hyperactivity (ADHD) Treatment

CompletedTreatment4 IdentifierTitleDrugs
NCT03610464Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
NCT00468143A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
NCT01986062Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
NCT00506727Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD